Physician profile
Bebi Bacchus
NPI 1689606915
$507.06
in general payments reported to CMS, 2019-2025
7 companies · $15.97 in 2025
The $15.97 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $203 · 2024: $289 · 2025: $15.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $507.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $507.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $163.76 | 2023-2024 | Flumist Quadrivalent, Evusheld |
| Ironshore Pharmaceuticals INC. | $147.91 | 2023-2024 | Jornay Pm |
| Genmab U.S., INC. | $87.46 | 2024 | Tivdak |
| Supernus Pharmaceuticals, INC. | $47.98 | 2023-2025 | Qelbree, Qelbree |
| Merck Sharp & Dohme LLC | $21.66 | 2024 | Gardasil, Vaxelis, Gardasil 9 |
| Sanofi Pasteur INC. | $20.20 | 2023 | |
| Noven Pharmaceuticals, INC. | $18.09 | 2024 | Xelstrym |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bebi Bacchus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.